Current Signal Transduction Therapy
Volume 15, 3 Issues, 2020
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
ISSN: 2212-389X (Online)
ISSN: 1574-3624 (Print)
This journal supports open access
Most Accessed Articles
Overview of Mechanisms of Cancer Stem Cell Drug Resistance
, 2013; 8(3): 180-192.Bozena Kaminska, Dorota Weronika Kulesza and Kavita Ramji
DOI: 10.2174/1574362409666140206221621
Astrocytic Signaling in Persistent Pain
, 2012; 7(1): 56-74.Yu-Xia Chu, Zhi-Qi Zhao and Feng Wei
DOI: 10.2174/157436212799278052
The Senescent Mesenchymal Stem Cells in Systemic Lupus Erythematosus
, 2013; 8(2): 173-177.Guijuan Feng, Wei Tan and Zhifeng Gu
DOI: 10.2174/15743624113089990003
Bladder Cancer and Stem Cells
, 2012; 7(3): 209-219.Tomasz Drewa, Sandra Krzyzanowska, Andrzej Marszalek and Anna Bajek
DOI: 10.2174/157436212802481556
Harmine Induces Gastric Cancer Cell Apoptosis through the ROSmediated PI3K/AKT Signaling Pathway
, 2015; 10(2): 112-118.Qingqing Ding, Zhuoyun Wang, Ke Ma and Qi Chen
DOI: 10.2174/1574362410666150625190713
The Effects of 5-Aza-2`-Deoxycytidine on DLC-1 Gene Expression, Methylation Level and Expression of Downstream Signaling Molecules Cdc42 in Multiple Myeloma
, 2015; 10(1): 31-35.Xianqi Feng, Ling Zhang, Shumin Nie, Zhan Su, Xue Shi, Yan Gao, Xiangyun Chen, Wenyuan Niu, Zhongguang Cui, Hongguo Zhao, Fanjun Meng and Chunting Zhao
DOI: 10.2174/1574362410666150311000910
Renal Cell Carcinoma Cancer Stem Cells as Therapeutic Targets
, 2013; 8(3): 203-209.Anna M. Czarnecka and Cezary Szczylik
DOI: 10.2174/1574362409666140206222251
Optimization of the Enzymolysis Conditions for Scorpion Peptides and Evaluation of its Antitumor Activity
, 2016; 11(1): 41-48.Fangwen Jiao, Jihui Wang, Yuhong Liu, Yan Zou, Wei Jia, Panpan Zhang, Jing Sun, Youwei Xu and Junxiang Wang
DOI: 10.2174/1574362411666160517113916
The Heterogeneity of Glioma Stem Cells
, 2014; 9(2): 70-77.Suojun Zhang, Feng Wan, Lin Han, Fei Ye, Dongsheng Guo and Ting Lei
DOI: 10.2174/1574362409666140901225437
Molecular Switch of AhR in Repression or Activation of Stem Cell Signaling
, 2017; 12(1): 28-33.Yingqiu Xie*, Xiuqing Zhang, Tomiris Atazhanova, Bindong Song and Qing Yang
DOI: 10.2174/1574362412666170207103318
Editor-in-Chief
Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)
Biography
The University of Oklahoma Health Science Center
Oklahoma City, OK
Biography
Biography of Jingxuan Yang
Dr. Yang obtained a doctorate (Ph.D.) in Molecular Biology & Biochemistry from Chinese Academy of Med. Sci. and Peking Union Med. College (CAMS & PUMC), Beijing, China. Currently Dr. Yang is an assistant professor in the University of Oklahoma Health Sciences Center. He has published more than 30 scientific publications and served as active editorial board member of Scientific Reports.
Dr. Yang is currently the Editor-in-Chief of this journal (Current Signal Transduction Therapy), published by Bentham Science Publishers.
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Signal Transduction Therapy was launched in 2006. Dr. Jingxuan Yang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net